RESMED INC — Director's Dealing 2020

Feb 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-02-18

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	ResMed Common Stock	F	1274	$174.80	Disposed	90700	Direct
2020-02-20	ResMed Common Stock	A	15370	$176.00	Acquired	106070	Direct
2020-02-20	ResMed Common Stock	F	9105	$176.00	Disposed	96965	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017.

F2: Represents performance-based restricted stock units granted on February 16, 2017. The shares were earned on February 20, 2020, when the compensation committee certified that the performance metrics were met.